Connect with us

Hi, what are you looking for?

Candida Infections Drugs Market to Hit US$ 19.73 Billion in the Forecast 2022-2029

Candida Infections Drugs market business report encompasses thorough analysis of the market with respect to several factors about healthcare industry that range from market drivers, market restraints, market segmentation, opportunities, challenges, and market revenues to competitive analysis. The market report presents CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. For market segmentation study, a market of potential customers is divided into groups or segments based on different characteristics such as end user and geographical region. Global Candida Infections Drugs market research report brings precise and exact market research information that drives the business into right direction.

The leading Candida Infections Drugs marketing report not only provides market segmentation in the most-detailed pattern but also conducts thorough analysis of patents and major market players to provide a competitive landscape. This industry analysis report provides market data even by considering new product development from beginning to launch. The report discusses the recent and future market trends and performs analysis of the impact of buyers, substitutes, new entrants, competitors, and suppliers on the market. Candida Infections Drugs market report broadly encompasses absolute and distinct analysis of the market drivers and restraints, major market players involved in this industry, exhaustive analysis of the market segmentation, and competitive analysis of the key players.

Download Sample PDF Copy of this Report to understand structure of the complete report (Including Full TOC, Table & Figures) @

Leading Key Players Operating in the Candida Infections Drugs Market Includes:

  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • AstraZeneca (U.K.)
  • Johnson & Johnson Private Limited (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Merck & Co., Inc. (U.S.)

Key Market Analysis and Insights:

The global candida infections drugs market is expected to witness significant growth during the forecast period. The growing prevalence rate of fungal infections such as candidiasis and aspergillosis is one of the key factors propelling the market. With respect to its treatment, the increasing popularity of over-the-counter (OTC) drugs such as econazole, ketoconazole, miconazole,clotrimazole, and amorolfine, many patients are found to be taking OTC drugs to obtain a prescription from a health professional.

Data Bridge Market Research analyses a growth rate in the global candida infections drugs market in the forecast period 2022-2029. The expected CAGR of the global candida infections drugs market tends to be around 4.00% in the mentioned forecast period. The market was valued at USD 14.42 billion in 2021, and it would grow up to USD 19.73 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Browse Full Report Along With Facts and Figures @

Global Candida Infections Drugs Market Scope and Market Size

The global candida infections drugs market is segmented on the basis of type, drug type, treatment, dosage form, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.


  • Athletes Foot
  • Oral Thrush
  • Vaginal Yeast Infection
  • Nail Fungus
  • Jock Itch
  • Diaper Rash

Drug Type

  • Azoles
  • Echinocandins
  • Other Drugs


  • Antibiotics
  • Benzodiazepines
  • Contraceptives
  • Hormone Replacement Therapy

Dosage Form

  • Gels and Creams
  • Lozenges
  • Tablets
  • Liquids
  • Sprays
  • Powders
  • Ointments


  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Others

Candida Infections Drugs Market, By Region:

Global Candida Infections Drugs market is analyzed and market size insights and trends are provided by country, product as referenced above.

The countries covered in the Candida Infections Drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the Candida Infections Drugs market because of the rise in the cases of arrhythmic diseases, favorable reimbursement policies for patients, high demand for advanced treatment methods and developed healthcare infrastructure in the region. Asia-Pacific is estimated to grow in the forecast period due to the high prevalence of cardiovascular diseases, increase in adoption of advanced digital devices, large population and launch of new innovative products.

Inquire Before Buying This Research [email protected]

Global Candida Infections Drugs Market Dynamics


  • Higher Demand for Azoles

Synthetic azoles and semi-synthetic compounds are widely used for more fungal infections and infections. These drugs are used to treat thrush, candidiasis, aspergillosis, yeast infection, tinea versicolor, athlete’s foot, ringworm, fungal infections, systemic mycosis, and seborrheic dermatitis. The azole group provides a broad spectrum of activity and improved safety standards. These medications have fewer side effects, worse drug interactions, and improved absorption and distribution properties. Thus, it acts as a major driver in market growth.

  • Increase in the number of research and development activities       

Moreover, the market’s growth is fueled by the rise in the number of research and development activities. This will provide beneficial opportunities for the global candida infection drugs market. To encourage researchers and pharmaceutical companies to develop novel medicines, the government funds research and development (R&D) initiatives.


  • Higher Drug Launches and Innovations

The development and innovation of many potential drugs support the competitiveness of the pharmaceutical market. The sale of both established agents and newly launched antifungal agents is important. For instance, in 2019, Mayne Pharma announced the launch of the TOLSURA 65mg capsule in the U.S. TOLSURA is a formulation of itraconazole that has been shown to treat fungal infections of the system, including histoplasmosis, blastomycosis, aspergillosis, and others. Therefore, all of these factors are projected to contribute to partial growth in the forecast period.

  • Increasing Demand for Retail Pharmacies

The increase in the number of drugs used for global candida infections delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily available.

Table of Contents: Global Candida Infections Drugs Market

1 Introduction
2 Market Segmentation
3 Executive Summary
4 Premium Insight
5 Market Overview
6 Covid-19 Impact on Candida Infections Drugs in Healthcare Industry
7 Global Candida Infections Drugs Market, by Product Type
8 Global Candida Infections Drugs Market, by Modality
9 Global Candida Infections Drugs Market, by Type
10 Global Candida Infections Drugs Market, by Mode
11 Global Candida Infections Drugs Market, by End User
12 Global Candida Infections Drugs Market, by Geography
13 Global Candida Infections Drugs Market, Company Landscape
14 Swot Analysis
15 Company Profiles
16 Questionnaire
17 Related Reports

Check Complete Table of Contents with List of Table and Figures @

Top Trending Reports of Healthcare Industry:

Drug Delivery Market Size, Report, Research, Demand, Value, & Forecast Analysis By 2029 l

Laser Capture Microdissection Market – Global Industry Trends and Forecast to 2028 |

Label-Free Detection Market – Global Industry Trends and Forecast to 2028 |

Viral Clearance Services Market – Global Industry Trends and Forecast to 2028 |

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-                                                                      

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:- [email protected]

Written By

You may also like:

Tech & Science

Oxford Research reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes.

Tech & Science

The ransomware attack on AirAsia serves as a sobering reminder of the growing threat to critical infrastructure globally.


Six million people were on Friday under Covid lockdown in a Chinese city home to the world's largest iPhone factory.


French retail giant Carrefour is still selling Brazilian beef products linked to destruction of the Amazon rainforest.